← Open Payments lookup

BRIANA TILLMAN: Open Payments

NPI 1619434545 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$669 in 29 payments from 12 companies in 2025. Trend: 2023 $303 · 2024 $213 · 2025 $669

Food & beverage: $669
CompanyPaymentsAmount
Alkermes, Inc.4$108
ABBVIE INC.3$94
Otsuka America Pharmaceutical, Inc.4$83
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$82
Takeda Pharmaceuticals U.S.A., Inc.3$69
Axsome Therapeutics, Inc.3$67
Lundbeck LLC2$38
Teva Pharmaceuticals USA, Inc.2$35
Neurocrine BioSciences, Inc.1$32
Boehringer Ingelheim Pharmaceuticals, Inc.1$23

Products named: REXULTI, VRAYLAR, CAPLYTA, TRINTELLIX, Auvelity, ARISTADA, VIVITROL, AUSTEDO XR.

Industry payments across CO — which companies pay providers there.